|Filed Under:||Mental Health / Alzheimer's|
|Posts on Regator:||271|
|Posts / Week:||3.4|
|Archived Since:||September 12, 2016|
Everyone has experienced the awkward situation of meeting someone and then forgetting their name shortly after. Among older adults, this happens more often than not. Researchers have discovered a new method to resolve this problem by tapping into a natural memory change during aging.
Inhibitory interneurons are particularly important for managing brain rhythms. Researchers have uncovered the therapeutic benefits of genetically improving these interneurons and transplanting them into the brain of a mouse model of Alzheimer's disease.
Psychologists found that when we learn the names of unfamiliar objects, brain regions involved in learning actively predict the objects the names correspond to.
Women with high physical fitness at middle age were nearly 90 percent less likely to develop dementia decades later, compared to women who were moderately fit, according to a new study. The study measured the women's cardiovascular fitness based on an exercise test.
Salk scientists discover that brain storage capacity is dynamic and varies by region.
To understand the link between aging and neurodegenerative disorders such as Alzheimer's disease, scientists compared the genetic clocks that tick during the lives of normal and mutant flies. They found that altering the activity ofShow More Summary
African Americans with a common genetic variation are at increased risk for developing Alzheimer's disease, while European Americans with the same variation are not, according to a new study.
Long-term proton pump inhibitor (PPI) use does not increase the risk of hip fracture among persons with Alzheimer's disease, according to a new study.
The protein FUS, whose mutation or disruption causes many cases of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), works as a central component of one of the most important regulatory systems in cells, according to a new study.
Researchers investigate the connection between misfolded proteins and the destruction of mitochondria in neurons.
New research improves our understanding of how motor nerve cells (neurons) respond to motor neuron disease, which could help us identify new treatment options.
Medical researchers have identified novel biomarkers of risk for future dementia.
Treatments targeted to enhance brain neurotrophic factor signaling could improve memory functions in Alzheimer's disease even though they don't alter brain amyloid burden, according to recent research.
Researchers profiled the epigenomic landscape of Alzheimer's brains, specifically in one of the regions affected early in AD, the lateral temporal lobe. They compared these to both younger and elderly cognitively normal control subjects. Show More Summary
For the first time, scientists have determined that an Alzheimer's disease (AD) polygenic risk score can be used to correctly identify adults with mild cognitive impairment (MCI) who were only in their 50s.
A genetics research team has solved a dilemma facing researchers who use genomewide association studies (GWAS) by developing a new approach that strategically 'filters' which genes are worth further study. The researchers hope this strategy...Show More Summary
Improving the trafficking of brain-cell proteins to reduce toxic buildup holds possibilities for new therapies against Alzheimer's disease.
If the sense of smell disappears, this can indicate a disease such as Alzheimer's or Parkinson's disease. However, unlike previously assumed, general degenerations in the nervous system do not play a leading role in the loss of the sense of smell with increasing age, but individual nerve cells or classes of nerves are decisive.
Scientists have developed a better understanding of a key protein associated with brain diseases including ALS (motor neuron disease) and dementia by studying how it enters central nervous system cells.
Scientists have found a new role for proteins that play important roles in asymmetric division, which may play a role in tumor formation or neurodevelopmental disorders.